Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

6 May 2015 07:01

RNS Number : 2642M
Wilmington PLC
06 May 2015
 

6 May 2015

Wilmington plc

Interim Management Statement

 

Wilmington plc ("Wilmington" or "the business"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight announces its Interim Management Statement for the nine month period to 31 March 2015 with comments reflecting trading to date.

 

Trading Update

As expected, Wilmington's revenue during the nine month period was up 7% on the same period last year. This continues the trends reported in the interim results for the six months ended 31 December 2014. Wilmington saw good revenue growth across all of its divisions except, as previously indicated, in the Legal division. Legal has witnessed underlying revenue decline due to ongoing structural changes but the rate of decline has continued to slow.

 

During the nine month period, Wilmington continued to see growth in reported operating profits and margins across all of its business divisions.

 

Operational Review

Wilmington Risk & Compliance: This division provides in-depth regulatory and compliance accredited training and information, market intelligence, and analysis. It focuses on the international financial services and international insurance markets as well as the UK pensions industry.

 

Wilmington Risk & Compliance delivered strong revenue and contribution growth during the period, especially within the Compliance business which continues to enjoy significant demand for its accredited face to face training in both public events and bespoke in-house assignments. In addition the Risk business, which primarily services the information needs of insurance and pensions professionals, saw solid growth in its revenue and profits.

 

Wilmington Finance: This division provides corporate finance and capital markets training as well as training and support services for qualified accountants in the UK in the profession and industry.

 

Finance recorded good revenue growth during what is traditionally a quiet period. In particular the international bank graduate induction training business has continued to secure major in-house training assignments and has a strengthening pipeline of projects for delivery into the summer which is the busiest part of its year. Given the operational gearing of the business the revenue growth has delivered an increase in both margin and profit.

 

Wilmington Legal: The Legal division provides a range of training, professional support services and information including Continuing Legal Education (CLE), expert witness training, databases and magazines to legal professionals.

 

The Legal division reduced the rate of decline in its revenue to five percent in the period, reflecting the further scaling back of some course programmes as we continue to integrate the division's activities and consolidate overlapping CLE courses. However, this revenue decline was offset by the flexible cost base and the continued strong performance from Bond Solon. Overall margins and profits were ahead compared to the same period in 2014.

 

Wilmington Insight: The Insight division provides analysis and clarity to customer-focused organisations, enabling them to better understand and connect with their markets.

 

Revenue in the healthcare business continued to show underlying growth across all main areas but in particular in NHiS which is enjoying increased demand for analyst led insightful information. The data suppression and charities businesses remain largely flat as expected. Overall profits and margins were up slightly on the same period in 2014.

 

Cash Flow

Net debt as at 31 March 2015 was £31.1m (31 March 2014 £34.6m) reflecting the reorganisation costs previously reported in interim results for the period to 31 December 2014.

 

Outlook

We continue to see the trends of tighter regulatory control and more complex legislation implemented in most of our key markets which in turn drives demand for many of our products and services. This demand is reflected in good ongoing momentum across most of our business. Overall, the financial performance is in line with the Board's expectations and Wilmington is on track to deliver against expectations for the full year.

 

-End-

For further information, please contact:

 Wilmington plc

Pedro Ros, CEO

Tony Foye, CFO

 

FTI Consulting

Charles Palmer / Emma Appleton

020 7422 6800

 

 

 

020 3727 1000

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately £200 million, Wilmington floated on the London Stock Exchange in 1995.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSPKPDDABKDPPK
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.